Global Lichen Sclerosus Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 1823

Lichen sclerosus (LS) is a skin disease of unknown cause, commonly appearing as whitish patches on the genitals, which can affect any body part of any person but has a strong preference for the genitals (penis, vulva) and is also known as balanitis xerotica obliterans (BXO) when it affects the penis. Lichen sclerosus is not contagious. There is a well-documented increase of skin cancer risk in LS, potentially improvable with treatment.
Topically applied corticosteroids to the LS-affected skin are the first-line treatment for lichen sclerosus in women and men, with strong evidence showing that they are "safe and effective" when appropriately applied, even over long courses of treatment, rarely causing serious adverse effects. They improve or suppress all symptoms for some time, which highly varies across patients, until it is required to use them again. Methylprednisolone aceponate has been used as a safe and effective corticosteroid for mild and moderate cases. For severe cases, it has been theorized that mometasone furoate might be safer and more effective than clobetasol.
In 2018, the global Lichen Sclerosus Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Lichen Sclerosus Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lichen Sclerosus Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
AstraZeneca
Valeant Pharmaceuticals
Sanofi
GlaxoSmithKline
Johnson & Johnson Services
Bristol-Myers Squibb Company
...

Market segment by Type, the product can be split into
Drug Therapy
Surgery

Market segment by Application, split into
Hospitals & Clinics
Dermatology Clinics
Pharmacies
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Lichen Sclerosus Treatment status, future forecast, growth opportunity, key market and key players.
To present the Lichen Sclerosus Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Lichen Sclerosus Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lichen Sclerosus Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Therapy
1.4.3 Surgery
1.5 Market by Application
1.5.1 Global Lichen Sclerosus Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals & Clinics
1.5.3 Dermatology Clinics
1.5.4 Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Lichen Sclerosus Treatment Market Size
2.2 Lichen Sclerosus Treatment Growth Trends by Regions
2.2.1 Lichen Sclerosus Treatment Market Size by Regions (2014-2025)
2.2.2 Lichen Sclerosus Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Lichen Sclerosus Treatment Market Size by Manufacturers
3.1.1 Global Lichen Sclerosus Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Lichen Sclerosus Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lichen Sclerosus Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Lichen Sclerosus Treatment Key Players Head office and Area Served
3.3 Key Players Lichen Sclerosus Treatment Product/Solution/Service
3.4 Date of Enter into Lichen Sclerosus Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Lichen Sclerosus Treatment Market Size by Type (2014-2019)
4.2 Global Lichen Sclerosus Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Lichen Sclerosus Treatment Market Size (2014-2019)
5.2 Lichen Sclerosus Treatment Key Players in United States
5.3 United States Lichen Sclerosus Treatment Market Size by Type
5.4 United States Lichen Sclerosus Treatment Market Size by Application

6 Europe
6.1 Europe Lichen Sclerosus Treatment Market Size (2014-2019)
6.2 Lichen Sclerosus Treatment Key Players in Europe
6.3 Europe Lichen Sclerosus Treatment Market Size by Type
6.4 Europe Lichen Sclerosus Treatment Market Size by Application

7 China
7.1 China Lichen Sclerosus Treatment Market Size (2014-2019)
7.2 Lichen Sclerosus Treatment Key Players in China
7.3 China Lichen Sclerosus Treatment Market Size by Type
7.4 China Lichen Sclerosus Treatment Market Size by Application

8 Japan
8.1 Japan Lichen Sclerosus Treatment Market Size (2014-2019)
8.2 Lichen Sclerosus Treatment Key Players in Japan
8.3 Japan Lichen Sclerosus Treatment Market Size by Type
8.4 Japan Lichen Sclerosus Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Lichen Sclerosus Treatment Market Size (2014-2019)
9.2 Lichen Sclerosus Treatment Key Players in Southeast Asia
9.3 Southeast Asia Lichen Sclerosus Treatment Market Size by Type
9.4 Southeast Asia Lichen Sclerosus Treatment Market Size by Application

10 India
10.1 India Lichen Sclerosus Treatment Market Size (2014-2019)
10.2 Lichen Sclerosus Treatment Key Players in India
10.3 India Lichen Sclerosus Treatment Market Size by Type
10.4 India Lichen Sclerosus Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Lichen Sclerosus Treatment Market Size (2014-2019)
11.2 Lichen Sclerosus Treatment Key Players in Central & South America
11.3 Central & South America Lichen Sclerosus Treatment Market Size by Type
11.4 Central & South America Lichen Sclerosus Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lichen Sclerosus Treatment Introduction
12.1.4 Pfizer Revenue in Lichen Sclerosus Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lichen Sclerosus Treatment Introduction
12.2.4 AstraZeneca Revenue in Lichen Sclerosus Treatment Business (2014-2019)
12.2.5 AstraZeneca Recent Development
12.3 Valeant Pharmaceuticals
12.3.1 Valeant Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lichen Sclerosus Treatment Introduction
12.3.4 Valeant Pharmaceuticals Revenue in Lichen Sclerosus Treatment Business (2014-2019)
12.3.5 Valeant Pharmaceuticals Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lichen Sclerosus Treatment Introduction
12.4.4 Sanofi Revenue in Lichen Sclerosus Treatment Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lichen Sclerosus Treatment Introduction
12.5.4 GlaxoSmithKline Revenue in Lichen Sclerosus Treatment Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Johnson & Johnson Services
12.6.1 Johnson & Johnson Services Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lichen Sclerosus Treatment Introduction
12.6.4 Johnson & Johnson Services Revenue in Lichen Sclerosus Treatment Business (2014-2019)
12.6.5 Johnson & Johnson Services Recent Development
12.7 Bristol-Myers Squibb Company
12.7.1 Bristol-Myers Squibb Company Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lichen Sclerosus Treatment Introduction
12.7.4 Bristol-Myers Squibb Company Revenue in Lichen Sclerosus Treatment Business (2014-2019)
12.7.5 Bristol-Myers Squibb Company Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details